Taken together with the increase in CCR7-positive T cells in tumor tissues (Fig. 3), the induction of SCM phenotypes could be one of the potential mechanisms of the enhanced antitumor efficacy of 7 × 19 CAR-T. This evidence concerns the gene CCR7 and neoplasm.